Agios Pharmaceuticals (AGIO) Receivables - Other (2016 - 2025)
Historic Receivables - Other for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q3 2025 value amounting to $5.0 million.
- Agios Pharmaceuticals' Receivables - Other rose 6128.93% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 6128.93%. This contributed to the annual value of $4.1 million for FY2024, which is 4622.78% up from last year.
- According to the latest figures from Q3 2025, Agios Pharmaceuticals' Receivables - Other is $5.0 million, which was up 6128.93% from $5.0 million recorded in Q2 2025.
- Agios Pharmaceuticals' 5-year Receivables - Other high stood at $8.1 million for Q2 2021, and its period low was $1.2 million during Q3 2023.
- In the last 5 years, Agios Pharmaceuticals' Receivables - Other had a median value of $3.5 million in 2024 and averaged $3.8 million.
- In the last 5 years, Agios Pharmaceuticals' Receivables - Other crashed by 6883.94% in 2023 and then surged by 16513.61% in 2024.
- Quarter analysis of 5 years shows Agios Pharmaceuticals' Receivables - Other stood at $7.0 million in 2021, then plummeted by 68.44% to $2.2 million in 2022, then increased by 27.38% to $2.8 million in 2023, then surged by 46.23% to $4.1 million in 2024, then increased by 22.39% to $5.0 million in 2025.
- Its last three reported values are $5.0 million in Q3 2025, $5.0 million for Q2 2025, and $3.3 million during Q1 2025.